A detailed history of Castleark Management LLC transactions in Natera, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 71,400 shares of NTRA stock, worth $11.6 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
71,400
Previous 74,000 3.51%
Holding current value
$11.6 Million
Previous $8.01 Million 13.24%
% of portfolio
0.38%
Previous 0.33%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $254,150 - $337,141
-2,600 Reduced 3.51%
71,400 $9.07 Million
Q2 2024

Aug 13, 2024

SELL
$85.28 - $112.6 $53,726 - $70,938
-630 Reduced 0.84%
74,000 $8.01 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $4.42 Million - $6.93 Million
74,630 New
74,630 $6.83 Million
Q3 2022

Nov 15, 2022

BUY
$36.93 - $56.68 $2.66 Million - $4.08 Million
71,950 New
71,950 $3.15 Million
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $3.21 Million - $9.66 Million
-105,739 Closed
0 $0
Q4 2021

Feb 16, 2022

SELL
$86.26 - $119.0 $926,432 - $1.28 Million
-10,740 Reduced 9.22%
105,739 $9.88 Million
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $495,841 - $625,482
4,950 Added 4.44%
116,479 $13 Million
Q2 2021

Aug 17, 2021

SELL
$86.05 - $119.72 $521,463 - $725,503
-6,060 Reduced 5.15%
111,529 $12.7 Million
Q1 2021

May 14, 2021

SELL
$91.47 - $124.36 $4.33 Million - $5.88 Million
-47,290 Reduced 28.68%
117,589 $11.9 Million
Q4 2020

Feb 17, 2021

SELL
$66.66 - $111.74 $4.35 Million - $7.29 Million
-65,200 Reduced 28.34%
164,879 $16.4 Million
Q3 2020

Nov 16, 2020

SELL
$45.89 - $72.67 $36,987 - $58,572
-806 Reduced 0.35%
230,079 $16.6 Million
Q2 2020

Aug 14, 2020

BUY
$26.36 - $49.86 $555,537 - $1.05 Million
21,075 Added 10.04%
230,885 $11.5 Million
Q1 2020

May 13, 2020

BUY
$17.27 - $40.17 $3.62 Million - $8.43 Million
209,810 New
209,810 $6.27 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.